Two years ago, our research group started an observational cohort study with longitudinal fecal sample collection to study the microbiota composition before and during hormonal therapy in postmenopausal breast cancer patients receiving aromatase inhibitors or tamoxifen. This evidence concerns the gene CYP19A1 and breast cancer.